Characterization Esophagus JOSEPH
A. MURRAY
of Nitric Oxide Synthase in the Opossum
and EUGENE
D. CLARK
Department of Internal Medicine, University of Iowa College of Medicine and Department of Veterans Affairs Medical Center, Iowa City, Iowa
Bac~found/Aims: Nitric oxide mediates the nonadrenergic, noncholinergic neural control of esophageal motor function. The purpose of this study was to characterize the NO synthase found in the muscularis propria of the opossum esophagus and determine its distribution along the esophagus. Methods: Esophageal muscle was homogenized in HEPES buffer and ultracentrifuged. The supernatant was exposed to [3H]L-arginine. The [3H]Lcitrulline produced by NO synthase was separated from [3H]L-arginine with a Dowex AG 50 W-X8 column (Biorad, Hercules, CA). Assays were performed in the presence and absence of Ca*+ or reduced nicotinamide adenine dinucleotide phosphate (NADPH). The distribution of NO synthase activity along the esophagus was determined. Results: The apparent Michaelis constant and maximum velocity of NO synthase were 7.5 k 1.4 pmol/L L-aginine and 76.0 2 17.3 pmol.mg protein-‘. min-I, respectively. The enzyme required both Ca2’ and NADPH for activity. Smooth muscle tissue from the lower esophageal sphincter and the esophageal body l-2 cm or 5-6 cm above the lower esophageal sphincter differed little in enzymatic activity, ranging from 0.97 to 1.27 pmol .mg wet wt’. min-‘. Striated muscle had less activity with 0.40 pmol. mg wet wt-l. mini. Conclusions: These data indicate the presence of a constitutive NO synthase in the esophagus of the opossum.
N
itric oxide or an NO-containing ates several neuromuscular
gus that result from activating ergic
(NANC)
substance
functions
of the esopha-
nonadrenergic,
nerves. ‘-’ Normally,
medi-
noncholin-
activating
NANC
nerves produce relaxation of the lower esophageal sphincter (LES) and contraction muscle. This contraction
of circular
esophageal
is called the off response because
it occurs after stimulation
of the nerve has ended. The
time between the end of the stimulus of the contraction along the length
smooth
and the beginning
is called the latency. The latency varies of the esophagus
such that it describes
a gradient with the latency being shortest in the proximal smooth
muscle
LES.6 Inhibitors (L-NNA),
esophagus
and longest
just
above
the
of NO synthase, like W-nitro-L-arginine
antagonize
the nerve-induced
relaxation
of the
LES and the membrane
hyperpolarization
ies this relaxation. 2,3 They antagonize circular esophageal gradient,
smooth muscle, eliminate
and antagonize
underlying mimics
some events produced the esophagus contractions
nearly simultaneous This
suggests
events
exogenous NO
by nerve stimulation.
and the LES.le3
Inhibitors
of
of swallow-induced
such that the contractions
along the length
that differences
It
circular smooth mus-
NO synthase also change the timing peristaltic
the latency
the electrophysiological
these responses.lX2 In addition,
relaxes the LES and hyperpolarizes cle from
that accompan-
the off responses of
become
of the esophagus4
in NO
synthase
along the esophagus may underlie the gradient
activity
in latency.
There are several isoforms of the enzyme NO synthase. One type requires reduced P-nicotinamide cleotide phosphate activity
(NADPH),
Ca’+ , and calmodulin
and is a constitutive
other type is inducible dependent.8
adenine dinu-
and does not appear to be calcium-
Alterations
in NO
synthase
activity
play a role in physiological
and pathophysiological
cesses affecting
function.
esophageal
of the basic biochemical activity
processes.
synthase
use L-arginine
produce
NO
produced
All of the isoforms of NO
and L-citrulline
in a 1:l
is difficult
and they all
ratio.
because its half-life
is very short in biological is a stable
product
that can be assayed. This is performed arginine
as the substrate
the formation
The
NO
to assay directly
however,
citrulline
prerequi-
roles of NO in the
as their substrate,
by this reaction
pro-
of the enzyme
is an essential
site to further studies of the possible
may
An understanding
characteristics
found in the esophagus
pathophysiological
for
form of the enzyme.’ An-
systems;
of the reaction by using {3H]~-
for NO synthase and following
of [3H)L-citrulline.9-”
Abbreviations used in this paper: BCA, bicinchoninic acid; CHAPS, 3-[(3cholamidopropyl)dimethylammoniol]-l-propanesulfonate; DlT, dithriotheritol; ECW, 50% inhibitory concentration; EGTA, ethylene glycol bis(baminoethyl ether) N,N,N’,N’-tetraacetic acid; L-NNA, A’“-nitro+arginine; reduced NADPH, P_nicotinamide adenine dinucleo tide phosphate; NANC, nonadrenergic, noncholinergic; PMSF, phenylmethylsulfonyl fluoride; TLC, thin-layer chromatography; V,,., maximum initial velocity. This is a U.S. government work. There are no restrictions on its use. 0018-5085/94/$0.00
June 1994
ESOPHAGEAL
These studies were undertaken first was to show the presence within the muscularis propria
for three purposes.
The
of NO synthase activity of the esophagus. Such
studies must be performed as part of a rigorous proof that NO is a mediator of NANC neural control of esophageal neuromuscular
function.
found in the esophageal
lature.
to confirm
We were unable
that the gradient the length
in latency
results
along in
activity.
Products
obtained
was obtained
(Boston,
from Bio-Rad
from Du Pont NEN
MA). Dowex
Laboratories
chromatography
obtained
(Hillsboro,
from
Whatman
phenylmethylsulfonyl nonradioactive
fluoride
L-arginine,
diaminetetraacetic leupeptin,
(EDTA),
CA). LK6 silica HEPES
A,
L-NNA,
ethylene-
ethylene
glycol
acid (EGTA),
3-[(3-cholamidopropyI)dimethyl(CHAPS),
and P-NADPH
from Sigma Chemical
obtained
(DTT),
L-ornithine,
ammoniol-1-propanesulfonate were obtained
Louis, MO). Bicinchoninic
buffer,
dithiothreitol
ether) N,N,N’,N’-tetraacetic
pepstatin
was
(TLC) plates were
OR).
(PMSF),
L-citrulline,
acid
bis-(P-aminoethyl
AG 5OW-X8
(Hercules,
gel 20 X 20-cm thin-layer
2-mercaptoethanol,
acid (BCA) protein
from Pierce (Rockford,
tions of [‘H]L-arginine,
(0.75-2.9
@/incubate);
incubation
blank contained
assay kits were
IL).
and 0 or 1 mmol/L
Two hundred
petted
into a scintillation
liquid
scintillant
Prospect, rulline
was eluted
lengthwise,
at its length
through
with a cuff of stomach.
in situ in a dissection
intraperi-
a midline and pinned
removed
by sharp dissection.
by gross inspection.
strips
(including
the
circular,
plexus
measuring
1 cm in width
unseparated
stopped
LSGOOOIC liquid
Instruments,
incubate
Inc., Fullerton,
5-6
and
muscle
were investigated.
the supernatant
and 2 cm in length)
were
of the esophagus
cm above the LES, and the striated
muscle
scintillation
0 or 0.45 mmol/L
mL of ice-cold
homogenization Tenbroech
buffer per gram tissue with a
tissue grinder
(Corning
Inc., Corning,
tration
NADPH
ity (V,,)
These
maximum
incubation
tants with
with
L-arginine,
by incubating
(pH 7.5). The homogenate 100,000 X g at 8°C.
EDTA,
at
The contribumixture
L-NNA
muscle
superna-
0.45 mmol/L
Ca*+ with 0.5
for 15 minutes
with
was present
in the
of L-NNA. activity
the tissue was homogenized
as previously
in buffer A or buffer B. Homogenization composition
0.1; EGTA,
0.001; leupeptin,
was
on tissue
inhibitor
the smooth
if any NO synthase
had the following
from each
spectrophotometry
10 l.tmol/L L-arginine,
fraction,
EDTA
0.5 mmol/L
to the incubation
The effect of the NO synthase
To ascertain
for these
times were 3,
the supernatant
10 PmoliL
calcium
concentrations
particulate described
for 60 minutes
media
The incubation
using atomic absorption
was investigated
the
initial veloc-
Ca’+ with 0.5 mmol/L
by incubating
segment
homogenates.
concen-
(K,) values were determined
EDTA, and 0- 1.5 mmol/L Ca*+ for 15 minutes. measured
EDTA,
NO synthase
The effect of calcium on the NO synthase
activity was estimated esophageal
10 pmol/
time and L-arginine
The
0.45 mmol/L
4, 5, and 15 minutes.
with
data were used to calculate
constant
velocities.
contained
segments
The apparent
and Michaelis
the initial
by incubating
for 15 minutes.
of incubation
was studied.
NY). Homogenization buffer A contained 50 mmol/L HEPES, 0.1 mg/mL PMSF, 0.5 mmol/L EDTA, and 1 mmol/L DTT was centrifuged
on
(Beckman
Ca’+ in 0.5 mmol/L
varying
motor-driven
of the
cm above the LES, 5-6
buffer until
in 9
counter
This was performed
mmol/L EDTA, and 1 .O mmol/L NADPH
The tissue was homogenized
by 2
4-mL eluate
CA).
esophagus 12.5 - 13.5 cm above the LES. The tissue strips were blotted dry, weighed, and kept in the ice-cold homogenization homogenized.
followed
The radioactivity
from the LES, l-2
tion of endogenous
myenteric
was
(Na+ form). Cit-
and the eluate were counted
and l- 19.4 /.tmol/L L-arginine.
of
of the mixture
of NO synthase activity along the length the Ca” requirement of esophageal NO and the NADPH requirement of esophageal NO
synthase
flat
were
Solve
Corp., Mt.
The distribution of the esophagus,
studies
muscle
Transverse
longitudinal,
cut from the LES, the smooth muscle segment and
counting.
a Beckman
was
COz) Krebs’ solu-
The circular
the LES was identified
l-2
International
2OO+L aliquot
was taken for scintillation
from
bath. The bath contained
(95% OJ5%
tion (pH 7.4). The mucosa and most of the submucosa quickly
inci-
The esophagus
washed in Krebs’ solution,
room temperature-oxygenated
Products
was pi-
6 mL Budget
with 2 mL of stop solution
intramuscularly
opened
of this mixture
vial containing
mL of water. An aliquot (0.8 mL) of the combined
initial reaction velocities.
and 50 mg/kg sodium pentobarbital
An buffer
500 PL stop buffer 1pH 5.5]/1 mmol/L
onto 1 mL of Dowex AG 5OW-X8
activity as a function
sion and removed
microliters
IL). A separate
pipetted
and 0 or 1.0 mmol/L
was exposed
50 PL of homogenization
(Research
Adult opossums of either sex were anesthetized with 30 mg/kg ketamine and 0.3 mg/kg acepromazine administered The esophagus
L-arginine
NADPH.
in place of the supernatant.
L L-arginine,
toneally.
1.0, or 1.5
10, or 19.4 FmoliL
cm above the LES, and the striated
NO Synthase Assay
to yield
buffer of 0.5 mmol/
0, 0.05, 0.1, 0.3, 0.4, 0.45, 0.5, 0.75,
synthase,
Co. (St.
varying concentra-
Ca*+, and NADPH
in the homogenization 9.72,
assay.
to 60 l.tL of
at 37°C for 3, 4, 5, or
contained
L-arginine,
Ca’+; 1, 4.86,
citrulline).
Materials [2,3,-‘H]L-arginine
The reaction mixture
was added
The reaction was stopped by adding (10 mmol/L EDTA/lOO mmol/L HEPES
Materials and Methods
Research
This was incubated
mixture.
mmol/L
hypothesis
from a gradient
reaction
15 minutes.
1445
was saved for protein
of the supernatant
L EDTA;
muscu-
of the off contraction
of the esophagus
NO synthase
the third
of the supernatant
Fifty microliters
final concentrations
The second was to characterize
the type of NO synthase
An aliquot
NO SYNTHASE
(in mmol/L.):
0.1; 2-mercaptoethanol,
buffer B
Tris/HCL,
50;
12; pepstatin
A,
0.002; and PMSF, 1.0 (pH 7.4). This buffer
1446
MURRAY
is similar
AND
CLARK
GASTROENTEROLOGY
to that described
the homogenate supernatant
(soluble)
particulate
fraction
and resuspended vol) glycerol
by Mitchell
was centrifuged and a pellet was washed
and 0 or 20 mmol/L
was mixed
for
100,000
X g. The solublized
fraction.
homogenization
volume
of
X g to yield a
(particulate)
with
to the original
CHAPS
et al.‘* An aliquot
at 100,000
30 minutes
The pellet
and
L NADPH,
0.3-0.75
with
recentrifuged
at
fraction was used for incubations.
incubations stopped
Ca*+, and either
0.5 mmol/L
EDTA
and 0.1 mmol/L
EGTA.
were for 15 minutes
as previously
Protein pernatant
described. by serial dilution
using the BCA method One milliliter 0.4% NaOH,
the Pierce BCA protein
and 95% NaHCO,
or PMSF and centrifuged
until
in measured without
with or without
protein
DTT To an
preparation.
The
1: 10% with reagent A and stored
There
was no significant
concentrations
between
difference
samples
with or
These studies committee
were approved
of the University
by the animal
care and use
of Iowa.
TLC a pathway pathway ornithine,
can be formed from L-arginine
other than NO synthase.
via
The most likely alternate
is the urea cycle. In the urea cycle, arginase generates which is converted
carbamylase.
determined
To investigate
to citrulline this
by ornithine
possibility,
trans-
TLC was per-
formed on the eluate from the Dowex column
and an aliquot
of the unseparated stopped incubation mixture. Proteins were removed from the stopped incubate before chromatography by adding 3 vol of 10% trichloroacetic acid and centrifuging the mixture
for 10 minutes
tritiated
amino acids of interest,
at 2000
X g at 6°C. To locate the 0.6 pg/mL
of nonradioactive
L-arginine, L-ornithine, and L-citrulline were each added to the samples. These were subsequently located using ninhydrin. A sample was applied above the preabsorbent area, and the silica gel below it was removed to keep it from migrating. This was used as a reference value to calculate the percentages of arginine, ornithine, and citrulline. methanol, chloroform, water, above the preabsorbent
The plates were developed in NH40H (4:l:l:l) for 16 cm
layer. Those portions
of the silica gel
as mean
? SEM and n represents observations
significance.
(pmol/mg
protein)
V, is the initial velocity (pmol . mg protein-’ (pmol
and
a is the
mg protein-i.
nonlinear
(~mol/L).‘*
formed
both
using
t is time with
time
were determined
by
X S)/(K, + S), in
initial velocity and S is the L-arginine The
nonlinear
Quasi-Newton
analysis
and Simplex
available as part of the Systat statistical
age (Systat Inc., Evanston,
were
at each time,
mini),
in velocity
analysis of the model. V = (V,,
concentration methods
change
Km and V,,
min-‘).
which V is the calculated
to deter-
The initial velocities
analysis using the model P = (V,)t +
(a?), in which P is measured in minutes,
were made.
t test was used when appropriate
by nonlinear
was perestimation
software pack-
IL).
Results NO synthase
activity
was sought
in both the par-
ticulate and supernatant fractions. We were unable to detect any activity in the particulate fraction, although several types of homogenizations and incubations were used. To control for the possibility that there may be segregation
of necessary cofactors in the soluble fraction,
we compared
an uncentrifuged
sample with soluble frac-
tion and were unable to detect any increase in total activity. All of the subsequent results refer to the supernatant in buffer A unless noted.
NO activity
along the esophagus
was measured
in the
LES, at two levels in the smooth
muscle
in the striated
There was little differ-
ence in NO
In theory, citrulline
sections
vials and counted.
from which
mine levels of statistical
fraction
DTT and PMSF.
of animals
The paired Student’s
A of
DTT and PMSF were added to final
assayed.
Data are expressed the number
so-
buffer did not interfere
equal to those in the enzyme
samples were diluted
at -2O’C
(reagent
as in the enzyme preparation.
aliquot of the supernatant, protein
0.16%
assay kit) and frozen. To make sure
with the assay, tissue was homogenized
acid and the reference
Analysis of Data
was diluted
2% Na2C03.H20,
that the D’M’ in the homogenization
concentrations
of the su-
with bovine serum albumin
of the supernatant
10 mL of 1% BCA-Na,
dium tartrate,
The
at 37”C, and the reaction was
assays were performed
as standards.13 with
mmol/L
or 0.1 mmol/L
of amino
into scintillation
No. 6
The
with 0 or 10% (~011
CHAPS.
by bands
were scraped
buffer
To control for the possibility that the enzyme in the particulate fraction was separated from required cofactor(s) in the soluble fraction during centrifugation, uncentrifuged aliquots of homogenate with 0 or 10% (vol/vol) glycerol were also incubated. The incubate consisted of 50 PL of sample preparation and final concentrations of 0 or 10 PglmL calmodulin, 1.0 mmol/ EDTA
occupied
Vol. 106,
muscle esophagus. synthase
activity
among
esophagus, tissues
from
and the
LES and the smooth muscle portion of the esophagus. There was no significant gradient of NO synthase activity measured along the smooth muscle segment of the esophagus. NO synthase activity in the striated muscle segment (12.5-13.5 cm above the LES) was significantly less than that of the smooth muscle segments (n = 5; P I
0.04) (Table 1). No significant difference in activity of the synthase was found wherever it was measured in terms of total tissue (pmol/[mg wet wt X min]) or extractable material (pmol/[mg protein X min]) in the smooth muscle (data not shown). Inclusion of the NO synthase inhibitor L-NNA with the smooth muscle incubates significantly inhibited the production of E3H]citrulline; as pmol . mg wet wtt’ . min-‘, the LES (n = 4) decreased from 0.986 5 0.096 to 0.041 + 0.018. The l-cm segment (n = 3) decreased from 1.187 ? 0.108 to 0.076 + 0.016, and the S-cm segment (n = 4) decreased from 1.369 k 0.131 to 0.008 ?
ESOPHAGEAL NO SYNTHASE
June1994
0.005.
The
estimated
(I&) for L-NNA 0.437 2 0.034 0.33
+ 0.073
inhibitory
for the 5-cm
by L-NNA
being
exchange formed
contained
each of ornithine
0.8% 90.5%
trulline.
There
activity. that
blanks
0.8%
with stop solution
ornithine,
was no net formation
and 9.0%
activity
TLC of the Dowex eluate
of the counts
The ratio of amino nine,
that there is no arginase
measured
distance
0.53 for L-ornithine,
verified
distance
(cm) to sol-
(cm) was 0.35 for L-argi-
formation was not linear over time. There was a decrease in enzyme activity of 7.2% per minute for low L-arginine centration tested. The initial velocities
in NO synthase
activity
with time
and concentration
be
statistics.
7.5+
at the highest
1.4 pmol/L
estimated
to
from
L-arginine, be
76.0
+
K,,, was estimated and the apparent 17.3
pmol.mg
to V,, pro-
con-
Calcium and NADPH Dependence of NO Synthase The NO synthase activity was Ca*+-dependent. Omission of Ca2+ from the incubates resulted in no citrulline formation (Table 1). The Ca2+ dependence of smooth muscle NO synthase from the various segments on added Ca*+ was further investigated by incubating the homogenates
were calculated
The apparent
tein-* . min-‘.
time and L-arginine concentration 1). The time course of citrulline
and 4.4% per minute
nonlinear was
and 0.90 for L-citrulline.
Using the buffer A homogenate from the whole muscularis propria (LES to 6 cm), the change in enzy-
concentrations
Figure 1. Change of L-arginine.
that
Kinetics of NO Synthase Activity
matic activity with was assayed (Figure
minutes
were from citrulline.
acid migration
vent front migration
by
10
5
ci-
of ornithine
This suggests
present.
Thin-
with stop solution
the supernatant. 95%-97%
and not Thin-layer
and citrulline.
of the incubate
arginine,
the radioactivity
resin was citrulline
of incubation
layer chromatographs
(n = 2).
the measured
in the incubations.
chromatographs
yielded
that
is caused by enzyme
from the Dowex
segment
confirms
TLC was also used to confirm ornithine
concentrations
are 0.465+ 0.005pmol/L for the LES, pmol/L. for the l-cm segment, and
pmol/L
The inhibition [3H)citrulline
50%
1447
with
different
concentrations
of Ca2+
15
20
the time
course of citrulline formation at different L-arginine concentrations and plotted (Figure 2). The enzymatic activity appears to follow Michaelis-Menten ing neither
substrate
activation
kinetics,
nor substrate
show-
inhibition
with increasing L-arginine concentrations. The apparent Km and V,, values were estimated from the MichaelisMenten equation using Quasi-Newton and Simplex
Table1. Distribution of NO Synthase Activity Along the Esophagus
LES 1 cm above LES 5-6 cm above LES Striated muscle (12.5 cm from LES)
0.45 mmol/L Ca and 1 mmol/ L NADPH
0.45 mmol/L Ca and no NADPH
No Ca and 1 mmol/L NADPH
1.27 ? 0.08 0.97 * 0.15 0.98 -c 0.06
0.59 + 0.08 0.39 + 0.04’ 0.48 ? 0.05
0.00 2 0.01 -0.01 ? 0.01 0.00 2 0.01
1 0
0.41 2 0.05
NOTE. All values are expressed SEM. n = 5. “n = 4.
0.28 2 0.03
as pmol.mg
wet wt-‘.min?
0.00 + 0.01
5
10
micromolar
arginine
and mean 2
figure 2. The instantaneous velocities for NO synthase activity as it varies with concentration of L-arginine.
1446
MURRAY
AND
GASTROENTEROLOGY
CLARK
esophageal
motor
function.
No. 6
As part of a rigorous
that NO is in fact a mediator of the esophagus,
Vol. 106,
of neuromuscular
the enzymatic
proof
function
system for its biosynthe-
sis must be shown in the muscularis
propria of the esoph-
agus. These studies confirm the presence of NO synthase in the muscle layers of the esophagus, our previous contention
thereby supporting
that NO is a mediator
of NANC
motor events in the esophagus. There are several isoforms of the enzyme NO synthase. One general 1.5 1.0 -
class of enzyme
and calmodulin
for activity.
of the enzyme
that is known
somes from the cerebellum.
P
requires
0.0
0.5
1111
1.5
1.0
Total
Cs (mM)
to be present
rations
of the opossum
Figure 3. The effect that increasing concentrations of added calcium has on NO synthase activity in three different segments of the esophagus.
that
and the CaZf chelator
EDTA
The estimated
of total added Ca2+ were 0.22
0.024
E&(s)
mmol/L
(0.5
for the LES
mmol/L) (Figure
(n =
6), 0.166
mmol/L for 1 cm (n = 5), and 0.14
2
+
0.018
3). 2
0.029
mmol/L
for 5 cm (n = 6). Figure 3 shows a rapid increase in NO synthase activity
as added Ca2+ is increased from 0.2 to
0.3 mmol/L. The activity is increased
decreases slightly
to 1.5 mmol/L.
To estimate
EC& values, the endogenous
calcium
measured by atomic absorption obtained 0.07
(LES, 0.08
mmol/L)
EDTA
The
mmol/L; 1 cm, 0.09
apparent
was calculated
with
stability
bility constant
stability
constant
mmol/L; 5 cm,
the added calcium constant
of calcium
values of EDTA” of calcium
was calculated
EDTA.16
X lo-l2 NADPH
duced NO synthase activity
The free
The ECSo values
mol/L for LES,
mol/L for 1 cm, and 4.8 X lo-l2 exogenous
synthase
re-
to about one half of control
of NADPH
activity
X
mol/L for 5 cm.
and to about two
thirds of the control values for the striated segment NO
6.9
from the incubate
values for the smooth muscle segments ble 1). The absence
log
and the
from the apparent sta-
by the method of Segal.”
for free Ca2+ were 9.9 Omitting
was
The values
at pH 7.5 from the negative
constant
Ca’+ concentration
lo-l2
concentration
spectrometry.
were summed
of the dissociation absolute
free calcium
and then ECSo values for free Ca2+ were
concentrations calculated.
as the Ca’+
at each
significantly level
(Ta-
decreased
of the esophagus
(P < 0.005).
A number
of previous
on cal-
in the rat cerebellum. NO
synthesis
The
is found
fraction was included with the solu-
would suggest
that at least in our prepara-
tion, there does not seem to be any activity in the particulate fraction
(data not presented).
The dependence
of the esophageal
ity on Ca 2+ is similar the rat brain cerebellum,” celLI NO
activity
calcium
concentration
slightly
inhibits
In all of these systems,
increases
to a maximum
is increased.
NO synthase.
added Ca2+ are comparable as rat cerebellum
for
the bovine aortic endothelial
and the rat forebrain.20 synthase
NO synthase activ-
to what has been reported
Adding
as the
more Ca2+
The ECSo values for total
with other preparations
or bovine aortic endothelial
such
cells. How-
ever, the EC>, for free Ca2+, even with estimates of endogenous Ca2+ added, are considerably bellum or bovine aortic endothelial because
the esophageal
zyme activity
nute incubations
protein-‘.min-’
at 22°C).
When
values were multiplied
had much
protein-‘.min-’
at 34°C compared
with 960 nmol.mg bations
preparations
(35 pmol.mg
lower than rat cerecells. This is probably less en-
for 15-mi-
with rat cerebellum for 5-minute
the esophagus-free
incu-
Ca’+
EC,,
by the ratio of cerebellum/esopha-
gus specific activity,
a mean free Ca*+ EC5o value for the
esophagus
of 197 t
segments
which is almost identical bellum.
The rat cerebellum
mmol/L EDTA,
41 nmol/L was obtained,
to the 200 nmol/L for rat cerehomogenates
contained
which was twice the concentration
in our preparations.
Comparison
1.0 used
with bovine aorta endo-
thelial cell enzyme, which also used 1.0 mmol/L EDTA, is not possible because the CaZf also bathed the rat lung
Discussion plays an important
ble fraction
is dependent
it similar to the constitutive
no additional
when the particulate
from our crude prepa-
esophagus
found
does
and is found in mac-
activity
making
form of the enzyme observation
form
in synapto-
Another type, inducible,
The enzymatic
cium and NADPH,
Ca’+,
It is the constitutive
not appear to be calcium-dependent rophages8
NADPH,
studies
suggest
role in the neuromuscular
that NO control
of
fibroblast
(RFL-6)
5’-cyclic
adenosine
Our
inability
cells used to detect NO by stimulated monophosphate
to show NO
production.‘”
synthase
activity
in the
ESOPHAGEAL NO SYNTHASE
June 1994
particulate
fraction
differs from data reported
from the
Our identification ated
other investigators
NADPH-diaphorase-positive
seems more dependent
tors than the soluble
fraction.
on some cofac-
Forstermann
et a1.19 found
muscle
of NO synthase
rat anococcygeus21 and vascular endothelium. The NO synthase activity in the particulate fraction observed by
However, plexus
esophagus
it is consistent
of the striated
fraction
personal
communication,
of bovine aortic endothelial cells had a partial dependence on exogenous calmodulin. Mitchell et al.” found signifi-
aphorase
staining
for NO
synthase
cant activity
tional
that the potassium
chloride-washed
in the particulate
geus, which was increased added.
whereas
of the anococcy-
when tetrahydrobiopterin
cells and rat anococcy-
the anococcygeus
muscle
required
but not added calmodulin.
tion of calmodulin
to our preparation
did not enhance
(data not shown).
The enzyme esophagus
activity
appear
and show neither bition
added
The addi-
of the LES and smooth
to follow Michaelis-Menten substrate
activation
muscle kinetics
nor substrate
This is similar to that of the constitutive enzyme found in the crude enzyme preparation of cerebellar synaptosomes (8.4 Fmol/L inhibited
L-arginine).’
the NO synthase
was consistent antagonists
activity
with the assumption are altering
sic inhibition
of 5’-cyclic
in rat cerebella
that the NO synthase of the latency
guanosine
monophosphate
exposed to 100 pmol/L IC5o of about 6 nmol/L
with L-NNA
the cerebellum
and
were incubated with L-NNA range, a monophasic inhibi-
This is similar
cerebellum
to that observed
in purified
esophageal
muscle along the length of the esophagus may be differentially sensitive to NO or that NO may be compartmentalized in a way that allows it to generate a gradient.
is in
the constitutive it is highly a gradient
characterization NO
synthase.
enzyme
It
seen in
calcium-dependent.
in NO synthase activity
that would be a basis for the timing
physiology.
1. Du C, Murray J, Bates J, Conklin JL. Nitric oxide: mediator of
2.
3.
4.
5.
6. 7.
8.
length of the esophagus.* One possible explanation for the latency gradient and its abolition by antagonists of NO synthase might be a gradient in NO synthase activity along the length of the esophagus. These studies do not support this hypothesis because no gradient in NO synthase activity was seen. It is possible that the smooth
muscle
may be endothelial
References
seems to be important
in setting the timing of peristaltic contractions resulting from swallowing. Inhibitors of NO synthase make swallow-induced contractions nearly simultaneous along the
neurons.23X24 The funcin the striated
of esophageal circular muscle contraction. Work is underway to further characterize this enzyme and its role in
rat
homogenates.22
NO release from enteric neurons
et al.,
NADPH-di-
as a specific stain
NANC-elaborated
in that
along the esophagus
tion response was observed with ICso values of about 400 nmol/L.
(Fang
1993).
this is the first enzymatic
We could not identify
for-
N-methyl-D-aspartate with an and about 600 nmol/L. When
smooth muscle supernatants over a similar concentration
Some of the activity
In summary,
by a
East et al.” found a bipha-
slices incubated
in myenteric
of the esophageal
that L-NNA
along the esophagus
the gradient
direct effect on NO synthesis. mation
The finding
esophagus
January
of
in the myenteric
origin.
with respect to L-arginine.
geal activity
muscle
in the striobservation.
the demonstration
neurons
role of the NO synthase
unknown.
inhi-
The K,,, for the esophahad a value of 7.5 +- 1.4 pmol/L L-arginine.
with
has been proposed
most closely resembles
but not added tetrahydrobiopt-
tetrahydrobiopterin activity
was
fractions seem to have different The aortic endothelial cells re-
quire added calmodulin erin,
fraction
Bovine aortic endothelial
geus muscle particulate cofactor requirements.
particulate
activity
was a surprising
1449
9.
10.
11.
12.
nonadrenergic noncholinergic hyperpolarization of opossum esophageal muscle. Am J Physiol 1991;261:G1012-G1016. Murray J, Du C. Ledlow A, Bates J, Conklin JL. Nitric oxide: mediator of nonadrenegic noncholinergic responses of opossum esophageal muscle. Am J Physiol 1991; 261:G401-G406. Conklin JL. Du C, MurrayJ, Bates JN. Characterization and mediator of inhibitory junction potentials from opossum lower esophageal sphincter. Gastroenterology 1993; 104:1439-1444. Yamato S, Spechler SJ, Goyal RK. Role of nitric oxide in esophageal peristalsis in the opossum. Gastroenterology 1992; 103: 197-204. Tottrup A, Svane D, Forman A. Nitric oxide mediating NANC inhibition in opossum lower esophageal sphincter. Am J Physiol 1991;260:G385-G389. Weisbrodt NW, Christensen J. Gradients of contractions in the opossum esophagus. Gastroenterology 1972;62:1159-1166. Forstermann U, Schmidt HHHW, Pollock JS, Sheng H, Mitchell JA, Warner TD, Nakane M, Murad F. lsoforms of nitric oxide synthase: characterisation and purification from different cell types. Bio them Pharmacol 1991;42:1849-1857. Stuehr DJ, Griffith OW. Mammalian nitric oxide synthases. In: Meister A, ed. Advances in enzymology. New York: Wiley, 1992; 296:287-344. Knowles RG, Palacios M. Palmer RMJ, Moncada S. Formation of nitric oxide from L-arginine in the central nervous system: a transduction mechanism for stimulation of the soluble guanylate cyclase. Proc Natl Acad Sci USA 1989;86:5159-5162. Palmer RMJ, Moncada S. A novel citrulline-forming enzyme implicated in the formation of nitric oxide by vascular endothelial cells. Biochem Biophys Res Commun 1989; 158:348-352. Bredt DS, Snyder SH. Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc Natl Acad Sci USA 1989;86:9030-9033. Mitchell JA, Forstermann U, Warner TD, Pollock JS, Schmidt HHHW, Heller M. Murad F. Endothial cells have a particulate enzyme system responsible for EDRF formation: measurement by vascular relaxation. Biochem Biophys Res Commun 1991;176:1417-1422.
1450
GASTROENTEROLOGY Vol. 106, No. 6
MURRAY AND CLARK
13. Smith RK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD. Measurement of protein using bicinchoninic acid. Anal Biochem 1985;150:76-85. 14. Scrimgeour KG. Chemistry and control of enzyme reactions. London: Academic, 1977. 15. Mendham J, Cooper D. Analytical chemistry by open learning classical methods. Volume 2. Chichester, England: Wiley, 1987. 16. Cheng KL, Veno K, lmamura T, eds. CRC handbook of organic analytical reagents. Boca Raton: CRC, 1982. 17. Segal J. Cation chelators and their utilization in the preparation of low concentrations of calcium. Biotechnol Appl Biochem 1986;8:423-429. 18. Bredt D, Snyder SH. Isolation of nitric oxide synthase, a calmodulin-requiring enzyme. Proc Natl Acad Sci USA 1990;87:682-685. 19. Forstermann U, Pollock J, Schmidt HHHW, Heller M, Murad F. Calmodulindependent endotheliumderived relaxing factor/nitric oxide synthase activity is present in the particulate and cytosolic fractions of bovine aortic endothelial cells. Proc Natl Acad Sci USA 1991;88:1788-1792. 20. East SJ, Garthwaite J. Nanomolar @-Nitroarginine inhibits NMDAinduced cyclic GMP formation in rat cerebellum. Eur J Pharmacol 1990; 184:311-313.
21.
Mitchell JA, Sheng H, Forstermann U, Murad F. Characterization of nitric oxide synthase in non-adrenergic noncholinergic nerve containing tissue from the rat anococcygeus muscle. Br J Pharmacol 1991; 104:289-291. 22. Struehr DJ, Griffith OW. Mammalian nitric oxide synthases. In: Meister A, ed. Advances in enzymology. Volume 65. New York: Wiley, 1992:287-346. 23. Hope BT, Micheal GT, Knigge KM, Vincent SR. Neuronal NADPH diaphorase is a nitric oxide synthase. Proc Natl Acad Sci USA 1991; 88:2811-2814. 24. Dawson TM, Bredt DS, Fotuhi M, Hwang PM, Snyder SH. Nitric oxide synthase and neuronal NADPH diaphorase are identical in brain and peripheral tissues. Proc Natl Acad Sci USA 1991;88:7797-7801.
Received May 17, 1993. Accepted February 1, 1994. Address requests for reprints to: Joseph A. Murray, M.D., Department of Internal Medicine, University of Iowa Hospitals & Clinics, Iowa City, Iowa 52242. Dr. Murray is the recipient of a career development award from the Department of Veterans Affairs.